Stephanie Marie Davis

Stephanie Marie Davis

Auto-generated profile, based on publicly available information

Stephanie Marie Davis

Division of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Atlanta; GA; and

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in The Lancet Global Health
Verified
Journal Article
Open access
JGJonathan M Grund
Jonathan M Grund
TBTyler S Bryant
Tyler S Bryant
IJInimfon Jackson
Inimfon Jackson
KCKelly Curran
Kelly Curran
NBNaomi Bock
Naomi Bock
SDStephanie M Davis
Stephanie M Davis
Male circumcision reduces men's risk of acquiring HIV and some sexually transmitted infections from heterosexual exposure, and is essential for HIV prevention in sub-Saharan Africa. Studies have also investigated associations between male circumcision and risk of acquisition of HIV and sexually transmitted infections in women. We aimed to review all evidence on associations between male circumcision and women's health outcomes to benefit women's health programmes. In this systematic review we searched for peer-reviewed and grey literature publications reporting associations between male circumcision and women's health outcomes up to April 11, 2016. All biomedical (not psychological or social) outcomes in all study types were included. Searches were not restricted by year of publication, or to sub-Saharan Africa. Publications without primary data and not in English were excluded. We extracted data and assessed evidence on each outcome as high, medium, or low consistency on the basis of agreement between publications; outcomes found in fewer than three publications were indeterminate consistency. 60 publications were included in our assessment. High-consistency evidence was found for five outcomes, with male circumcision protecting against cervical cancer, cervical dysplasia, herpes simplex virus type 2, chlamydia, and syphilis. Medium-consistency evidence was found for male circumcision protecting against human papillomavirus and low-risk human papillomavirus. Although the evidence shows a protective association with HIV, it was categorised as low consistency, because one trial showed an increased risk to female partners of HIV-infected men resuming sex early after male circumcision. Seven outcomes including HIV had low-consistency evidence and six were indeterminate. Scale-up of male circumcision in sub-Saharan Africa has public health implications for several outcomes in women. Evidence that female partners are at decreased risk of several diseases is highly consistent. Synergies between male circumcision and women's health programmes should be explored. US Centers for Disease Control and Prevention and Jhpiego.

1 August 2018 in BMJ Open
Verified
Journal Article
Open access
PDF file
SDStephanie M Davis
Stephanie M Davis
JHJonas Z Hines
Jonas Z Hines
MHMelissa Habel
Melissa Habel
JGJonathan M Grund
Jonathan M Grund
RRRenee Ridzon
Renee Ridzon
CTCarlos Toledo
Carlos Toledo
Objective This article provides an overview and interpretation of the performance of the US President’s Emergency Plan for AIDS Relief’s (PEPFAR’s) male circumcision programme which has supported the majority of voluntary medical male circumcisions (VMMCs) performed for HIV prevention, from its 2007 inception to 2017, and client characteristics in 2017. Design Longitudinal collection of routine programme data and disaggregations. Setting 14 countries in sub-Saharan Africa with low baseline male circumcision coverage, high HIV prevalence and PEPFAR-supported VMMC programmes. Participants Clients of PEPFAR-supported VMMC programmes directed at males aged 10 years and above. Main outcome measures Numbers of circumcisions performed and disaggregations by age band, result of HIV test offer, procedure technique and follow-up visit attendance. Results PEPFAR supported a total of 15 269 720 circumcisions in 14 countries in Southern and Eastern Africa. In 2017, 45% of clients were under 15 years of age, 8% had unknown HIV status, 1% of those tested were HIV+ and 84% returned for a follow-up visit within 14 days of circumcision. Conclusions Over 15 million VMMCs have been supported by PEPFAR since 2007. VMMC continues to attract primarily young clients. The non-trivial proportion of clients not testing for HIV is expected, and may be reassuring that testing is not being presented as mandatory for access to circumcision, or in some cases reflect test kit stockouts or recent testing elsewhere. While VMMC is extremely safe, achieving the highest possible follow-up rates for early diagnosis and intervention on complications is crucial, and programmes continue to work to raise follow-up rates. The VMMC programme has achieved rapid scale-up but continues to face challenges, and new approaches may be needed to achieve the new Joint United Nations Programme on HIV/AIDS goal of 27 million additional circumcisions through 2020.

17 September 2013 in BMC Public Health
Verified
Journal Article
Open access
PDF file
SDStephanie Davis
Stephanie Davis
DFDaniel Feikin
Daniel Feikin
HJHope L Johnson
Hope L Johnson
Two of the most prevalent causes of severe bacterial meningitis in children, Haemophilus influenzae type B (Hib) and Streptococcus pneumoniae, are preventable by existing vaccines increasingly available in developing countries. Our objective was to estimate the dose-specific effect of Hib and pneumococcal conjugate vaccines (PCV) on childhood meningitis mortality in low-income countries for use in the Lives Saved Tool (LiST).

5 November 2014 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
PDF file
SDStephanie M. Davis
Stephanie M. Davis
CWCaitlin M. Worrell
Caitlin M. Worrell
RWRyan E. Wiegand
Ryan E. Wiegand
KOKennedy O. Odero
Kennedy O. Odero
PSParminder S Suchdev
Parminder S Suchdev
LFLeAnne M. Fox
LeAnne M. Fox
Soil-transmitted helminths (STHs) are controlled by regular mass drug administration. Current practice targets school-age children (SAC) preferentially over pre-school age children (PSAC) and treats large areas as having uniform prevalence. We assessed infection prevalence in SAC and PSAC and spatial infection heterogeneity, using a cross-sectional study in two slum villages in Kibera, Nairobi. Nairobi has low reported STH prevalence. The SAC and PSAC were randomly selected from the International Emerging Infections Program's surveillance platform. Data included residence location and three stools tested by Kato-Katz for STHs. Prevalences among 692 analyzable children were any STH: PSAC 40.5%, SAC 40.7%; Ascaris: PSAC 24.1%, SAC 22.7%; Trichuris: PSAC 24.0%, SAC 28.8%; hookworm < 0.1%. The STH infection prevalence ranged from 22% to 71% between sub-village sectors. The PSAC have similar STH prevalences to SAC and should receive deworming. Small areas can contain heterogeneous prevalences; determinants of STH infection should be characterized and slums should be assessed separately in STH mapping.

6 May 2015 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
PDF file
SDStephanie M. Davis
Stephanie M. Davis
RWRyan E. Wiegand
Ryan E. Wiegand
FMFridah Mulama
Fridah Mulama
EKEdmund Ireri Kareko
Edmund Ireri Kareko
RHRobert Harris
Robert Harris
KWKimberly Y. Won
Kimberly Y. Won
Schistosoma mansoni infection is a major cause of organomegaly and ultimately liver fibrosis in adults. Morbidity in pre-school-aged children is less defined, and they are currently not included in mass drug administration (MDA) programs for schistosomiasis control. We report results of a study of the association of schistosomiasis with organomegaly in a convenience sample of 201 children under 7 years old in Rusinga, Kenya on two cross-sectional visits, before and after praziquantel treatment. Data included stool examination and serology for schistosomiasis, the Niamey ultrasound protocol to stage hepatosplenic morbidity including organomegaly, and potential confounders including malaria. Unadjusted and adjusted Poisson regressions were performed. The baseline prevalence of schistosomiasis by antibody and/or stool was 80.3%. Schistomiasis was associated with hepatomegaly (adjusted prevalence ratio [aPR] = 1.4; 95% confidence interval [CI]: 1.0–2.1) and splenomegaly (aPR = 2.1; 95% CI: 1.2–3.7). The association with hepatomegaly persisted posttreatment (aPR = 1.4; 95% CI: 1.1–1.6). Schistosomiasis was associated with morbidity in this cohort. Efforts to include young children in mass treatment campaigns should intensify.

28 November 2024 in MMWR. Morbidity and Mortality Weekly Report
Verified
Journal Article
Open access
MPMegan E Peck
Megan E Peck
SDStephanie Davis
Stephanie Davis
EOElijah Odoyo-June
Elijah Odoyo-June
JMJonathan Mwangi
Jonathan Mwangi
EOElvis Oyugi
Elvis Oyugi
RBRamona Bhatia
Ramona Bhatia
This report describes PrEP initiations in 37 countries as part of the United Nations Programme on HIV/AIDS.